Clinical trials
Follow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Guizhou Univ. of Traditional Chinese Medicine Progesterone receptor (PGR) compound 3h: sourced facts only. name: "Label-free surface plasmon resonance(SPR)assays verified direct binding of 3 h to Progesterone receptor (PGR) (KD = 2.41 × 10-6 M; ka = 70.07 × 103 M-1·s-1, kd = 16.87 × 10-2 s-1, τ = 5.93 s), confirming target engagement." [PMID:41924842]; target: "Label-free surface plasmon resonance(SPR)assays verified direct binding of 3 h to Progesterone receptor (PGR) (KD = 2.41 × 10-6 M; ka = 70.07 × 103 M-1·s-1, kd = 16.87 × 10-2 s-1, τ = 5.93 s), confirming target engagement." [PMID:41924842]; developer: "College of Pharmacy, Guizhou University of Traditional Chinese Medicine, Guiyang 550025, China." [PMID:41924842]
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Guizhou Univ. of Traditional Chinese Medicine Progesterone receptor (PGR) compound 3h.